Inhibiting cancer metastasis via targeting NAPDH oxidase 4

Biochemical Pharmacology

Volumn 86, Issue 2, 2013, Pages 253-266

  Zhang, Biao ^a   Liu, Zhen ^a   Hu, Xun ^a  

^a A Key Laboratory of Molecular Biology in Medical Sciences   (China)

Author keywords

Metastasis; NOX4; Reactive oxygen species (ROS); Schisandrin B; TGF b

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SCHIZANDRIN B; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84884900677     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.05.011     Document Type: Article

References (42)

1. Sporn MB. The war on cancer. Lancet 1996;347(9012):1377.
2. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10(1- 3):1881-96. (Pubitemid 40529044)
3. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000;279(6):L1005-28. (Pubitemid 32009487)
4. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 2006;25(4):695-705.
5. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87(1):245-313. (Pubitemid 46209993)
6. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68(6):1777-85. (Pubitemid 351416563)
7. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, et al. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 2009;69(6):2647-54.
8. Graham KA, Kulawiec M, Owens KM, Li X, Desouki MM, Chandra D, et al. NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther 2010;10(3):223-31.
9. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent- Chevallier O, et al. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocr-relat cancer 2010;17(1):27-37.
10. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 2007;67(22):10823-30. (Pubitemid 350145911)
11. Shimada K, Fujii T, Anai S, Fujimoto K, Konishi N. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder. BMC Urol 2011;11(1):22.
12. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005;97(9): 900-7. (Pubitemid 41552675)
13. Hu T, Ramachandra Rao SP, Siva S, Valancius C, Zhu Y, Mahadev K, et al. Reactive oxygen species production via NADPH oxidase mediates TGF-binduced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol 2005;289(4):F816-25. (Pubitemid 41324203)
14. Diebold I, Petry A, Hess J, Gorlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 2010;21(12): 2087-96.
15. Boudreau HE, Casterline BW, Rada B, Korzeniowska A, Leto TL. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to- mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med 2012;53(7):1489-99.
16. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999;27(5):612-6. (Pubitemid 29408648)
17. Cox B, Emili A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc 2006;1(4):1872-8. (Pubitemid 46778056)
18. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 2010;107(35):15565-70.
19. Block K, Gorin Y, Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci USA 2009;106(34):14385-90.
20. Tan AS, Berridge MV. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods 2000;238(1):59-68. (Pubitemid 30175986)
21. Sharma OP, Bhat TK. DPPH antioxidant assay revisited. Food Chem 2009;113 (4):1202-5.
22. Geback T, Schulz MM, Koumoutsakos P, Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009;46(4):265-74.
23. Robinson KM, Janes MS, Beckman JS. The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 2008;3(6):941-7. (Pubitemid 351818682)
24. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001;20.2. 20.2.1-16.
25. Nam JS, Suchar AM, Kang MJ, Stuelten CH, Tang B, Michalowska AM, et al. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor b in a mouse model of breast cancer. Cancer Res 2006;66(12):6327-35.
26. Safholm A, Tuomela J, Rosenkvist J, Dejmek J, Harkonen P, Andersson T. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clin Cancer Res 2008;14(20):6556-63.
27. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410(6824):50-6. (Pubitemid 32225831)
28. Bandyopadhyay A, Wang L, Agyin J, Tang Y, Lin S, Yeh IT, et al. Doxorubicin in combination with a small TGFb inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS ONE 2010;5(4):e10365.
29. Liu Z, Zhang B, Liu K, Ding Z, Hu X. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS ONE 2012;7(7):e40480.
30. Buul JD, Fernandez-Borja M, Anthony E, Hordijk P. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 2005;7(3-4):308-17. (Pubitemid 40279800)
31. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006;18(1):69-82. (Pubitemid 41415716)
32. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, et al. The superoxide-producing NAD (P) H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005;10(12):1139-51. (Pubitemid 41830073)
33. Bolte S, Cordelieres F. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006;224(3):213-32. (Pubitemid 46010930)
34. Janda E, Nevolo M, Lehmann K, Downward J, Beug H, Grieco M. Raf plus TGFbdependent EMT is initiated by endocytosis and lysosomal degradation of Ecadherin. Oncogene 2006;25(54):7117-30. (Pubitemid 44764181)
35. Saitoh M, Shirakihara T, Miyazono K. Regulation of the stability of cell surface E-cadherin by the proteasome. Biochem Biophys Res Commun 2009;381(4): 560-5.
36. Ip SP, Ko KM. The crucial antioxidant action of schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene. Biochem Pharmacol 1996;52(11):1687-93.
37. Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fernandez-Rodriguez CM, Pinedo F, et al. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE 2012;7(9): e45285.
38. Hancke J, Burgos R, Ahumada F. Schisandra chinensis (Turcz.) Baill. Fitoterapia 1999;70(5):451-71.
39. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15(3):220-31.
40. Ebos JML, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011;8(4):210-21.
41. Man S, Zhang Y, Gao W, Yan L, Ma C. Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma. Clin Exp Metastasis 2008;25(8): 855-64.
42. Price JT, Quinn JMW, Sims NA, Vieusseux J, Waldeck K, Docherty SE, et al. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 2005;65(11):4929-38. (Pubitemid 40740833)